Clinical Trial Update: Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a reduced-intensity transplant conditioning regimen for severe thalassemia has completed, with results posted in October 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Thalassemia

Snippet

Sponsor: Washington University School of Medicine | Conditions: Severe Thalassemia | Phase 2 | Status: COMPLETED | Results posted: 2017-10-20